Federated Hermes
IMRX icon

Federated Hermes’s Immuneering IMRX Stock Holding History

Federated Hermes’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,954
Closed -$6.01K – 2118
2025
Q1 		$6.01K Buy
3,954
+116
+3% +$211 ﹤0.01% 1855
2024
Q4 		$8.44K Sell
3,838
-1,297
-25% -$2.69K ﹤0.01% 1854
2024
Q3 		$12.8K Buy
5,135
+626
+14% +$910 ﹤0.01% 1788
2024
Q2 		$5.77K Buy
+4,509
New +$7.41K ﹤0.01% 1824
2023
Q4 		– Sell
-75
Closed -$576 – 2111
2023
Q3 		$576 Sell
75
-38
-34% -$349 ﹤0.01% 2035
2023
Q2 		$1.15K Buy
+113
New +$1.09K ﹤0.01% 2022

Other funds holding IMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Federated Hermes's IMRX Position: Q2 2025 in Review

Federated Hermes sold out of Immuneering (IMRX) in Q2 2025, closing a stake of 3,954 shares — an estimated $6.01K sold.

Federated Hermes first reported a position in IMRX in Q2 2023 and held it in 6 quarters. The position peaked at $12.8K in Q3 2024. 39 funds tracked by Wall St. Rank hold IMRX as of Q2 2025.

  • Federated Hermes reported no remaining Immuneering position as of Q2 2025 after selling out during the quarter.
  • Federated Hermes sold 3,954 Immuneering shares in Q2 2025, an estimated $6.01K.
  • Federated Hermes first reported a position in Immuneering in Q2 2023 and held it in 6 quarters.
  • Federated Hermes's Immuneering position peaked at $12.8K in Q3 2024.
  • 39 funds tracked by Wall St. Rank held Immuneering as of Q2 2025.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.